| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |